H
Halozyme Therapeutics
Biotech & Life Sciences · San Diego, United States · Founded 1998 · IPO 2004
Investors
2 investors on Halozyme Therapeutics's cap table
Sourced from Dealroom's funding history.
Global footprint
Where Halozyme Therapeutics has talent and traffic
across markets
Talent graph
The shape of Halozyme Therapeutics's talent
Dealroom maps Halozyme Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$156M patent portfolio · 88 active families
Where Halozyme Therapeutics concentrates vs peers
Each axis is a top-10 topic across Halozyme Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Halozyme Therapeutics's 3 investments and acquisitions.
Every disclosed deal where Halozyme Therapeutics appeared as a backer or acquirer, 2022–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Halozyme Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Halozyme Therapeutics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Halozyme Therapeutics
An AI-synthesized read of the highest-engagement posts about Halozyme Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Halozyme Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.